Learn more about Ariadne Labs' response to COVID-19

Don Berwick

Donald M. Berwick, MD, MPP, FRCP is president emeritus and senior fellow at the Institute for Healthcare Improvement (IHI), an organization that Dr. Berwick co-founded and led as president and CEO for 18 years. He is one of the nation’s leading authorities on health care quality and improvement.

Read MoreRead Less

Elliot Cohen

Elliot Cohen is the co-founder and Chief Product Officer of PillPack, which was acquired by Amazon in 2018. He is a senior lecturer at MIT’s Sloan School of Management and a Founder Partner at Founder Collective. Prior to co-founding PillPack, he founded and directed MIT’s Hacking Medicine program. Mr. Cohen graduated from UC Berkeley with a degree in computer science and cognitive science. Mr. Cohen also has an MBA from MIT’s Sloan School of Management.

Andrew Dreyfus

Andrew Dreyfus is president and chief executive officer for Blue Cross Blue Shield of Massachusetts. Serving nearly 3 million members, BCBSMA is one of the largest independent, not-for-profit Blue Cross Blue Shield plans in the country. As CEO, Dreyfus leads the company’s effort to make quality health care affordable.

Read MoreRead Less

Atul Gawande*

Founder, Chairman of the Governance Council

Atul Gawande, MD, MPH, is a surgeon, writer, and public health leader. He is a practicing endocrine surgeon at Brigham and Women’s Hospital and a professor at Harvard Medical School and the Harvard T.H. Chan School of Public Health. He is the founder and chair of Ariadne Labs, a joint center for health systems innovation, and of Lifebox, a nonprofit organization making surgery safer globally. He is also a founder of CIC Health, which is accelerating the scale up of COVID-19 testing and vaccine distribution nationally. From 2018-2020, he was CEO of Haven, the Amazon, Berkshire Hathaway, and JPMorgan Chase health care venture.

Read MoreRead Less

Peter Hecht

Peter Hecht, Ph.D has served as Ironwood’s CEO and a director since co‐founding the company in 1998. He started Ironwood because he was attracted to “the idea of working with a team of people who challenge, inspire and humble me,” and building an enduring organization dedicated to creating important medicines.

Read MoreRead Less

Eric S. Lander

Eric Lander, Ph.D. is the founding director and serves as a core member of the Broad Institute of MIT and Harvard. One of the principal leaders of the Human Genome Project, he and his colleagues have a long-standing interest in applying genomics to understand the molecular basis of human physiology and disease.

Read MoreRead Less

Karin S. Leschly, MD, FAAFP

Karin S. Leschly, MD, FAAFP, serves as the Medical Director of Quality Improvement and Population Health at the East Boston Neighborhood Health Center, one of the largest federally qualified community health centers in the nation.

Read MoreRead Less

Elizabeth Nabel*

Elizabeth Nabel, M.D. is the president of Brigham and Women’s Health Care (BWHC), comprised of BWH and Brigham and Women’s Faulkner Hospital. Prior to her position at BWHC, Dr. Nabel served as the director of the National Heart, Lung, and Blood Institute at the National Institutes of Health. In this capacity, Dr. Nabel oversaw an extensive national research portfolio with an annual budget of approximately $3 billion to prevent, diagnose, and treat heart, lung, and blood diseases.

Read MoreRead Less

Michelle Williams*

Michelle Williams, ScD, SM, MS, is the Dean of Harvard T.H. Chan School of Public Health. Prior to her appointment as Dean, Williams was the chair of the Epidemiology Department and a Stephen B. Kay Family Professor of Public Health and Global Health and Population at the Harvard T.H. Chan School of Public Health. She has received countless awards for her work including the Presidential Award for Excellence in Science, Mathematics, and Engineering Mentoring.

Read MoreRead Less

Jason Yeung

Jason Yeung, M.Phil. is a managing director and portfolio manager at Morgan Stanley with a focus on Investment Management Growth Funds. His career has focused on investments in the healthcare space. He also serves as a board member of Lifebox Foundation Inc. and co-chair of the Young Partners Board of the Public Theater of New York City.

Read MoreRead Less

Gwill York

Gwill York, MBA, is a pioneering entrepreneur with 30 years of experience financing early-stage technology and healthcare companies.  Gwill co-founded Lighthouse Capital Partners in 1994, a structured venture capital partnership based in Cambridge and Menlo Park.  At Lighthouse, she led investments in companies such as Vertex Pharmaceuticals, Millennium Pharmaceuticals, Cascade Communications, Sirocco Systems, Speechworks, Storage Networks and Netflix.

Read MoreRead Less